Search of Chemical Scaffolds for Novel Antituberculosis Agents
暂无分享,去创建一个
Ramón García-Domenech | Jorge Gálvez | Rafael Borrás | R. García-Domenech | J. Gálvez | J. D. de Julián-Ortiz | A. García-García | C. Muñoz | R. Guna | R. Borrás | Angeles García-García | Carlos Muñoz | Remedios Guna | Jesus Vicente de Julián-Ortiz | R. García-Domènech
[1] R. García-Domenech,et al. General topological patterns of known drugs. , 2001, Journal of molecular graphics & modelling.
[2] J. Gálvez,et al. New Analgesics Designed by Molecular Topology , 1996 .
[3] Ramón García-Domenech,et al. New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. , 2003, Journal of Antimicrobial Chemotherapy.
[4] J. Ungwitayatorn,et al. Quantitative structure-activity relationship (QSAR) study of polyhydroxyxanthones. , 1997, Pharmaceutica acta Helvetiae.
[5] E Uriarte,et al. Recent advances on the role of topological indices in drug discovery research. , 2001, Current medicinal chemistry.
[6] D. Bonchev,et al. Overall connectivity--a next generation molecular connectivity. , 2001, Journal of molecular graphics & modelling.
[7] Ramon Carbó-Dorca,et al. Similarity approach to QSAR. Application to antimycobacterial benzoxazines. , 2004, International journal of pharmaceutics.
[8] Ramón García-Domenech,et al. Molecular connectivity to find β-blockers with low toxicity , 1997 .
[9] A Tropsha,et al. Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining. , 2001, Current pharmaceutical design.
[10] J. Gálvez,et al. Molecular topology: a useful tool for the search of new antibacterials. , 2000, Bioorganic & medicinal chemistry letters.
[11] R. R. Hocking. Criteria for Selection of a Subset Regression: Which One Should Be Used? , 1972 .
[12] D. Mitchison,et al. Early Bactericidal Activity of Paromomycin (Aminosidine) in Patients with Smear-Positive Pulmonary Tuberculosis , 2000, Antimicrobial Agents and Chemotherapy.
[13] A. E. Hoerl,et al. Ridge regression: biased estimation for nonorthogonal problems , 2000 .
[14] M. Iseman,et al. The increasing prevalence of resistance to antituberculosis chemotherapeutic agents: implications for global tuberculosis control. , 1992, Current clinical topics in infectious diseases.
[15] E. Besalú,et al. Virtual generation of agents against Mycobacterium tuberculosis. A QSAR study , 2004, Molecular Diversity.
[16] J. Maddry,et al. Antimycobacterial activity of 1-deaza-7,8-dihydropteridine derivatives against Mycobacterium tuberculosis and Mycobacterium avium complex in vitro. , 2001, The Journal of antimicrobial chemotherapy.
[17] Feldman Wh. Chemotherapy of Tuberculosis , 1946 .
[18] J. Rugutt,et al. Relationships between Molecular Properties and Antimycobacterial Activities of Steroids , 2002, Natural product letters (Print).
[19] W. Steinmetz. A CoMFA Model of Steric and Electronic Effects of Phosphorus Ligands , 1996 .
[20] T. Shinnick,et al. Mycobacterial taxonomy , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[21] L B Kier,et al. General definition of valence delta-values for molecular connectivity. , 1983, Journal of pharmaceutical sciences.
[22] A. García-García,et al. QSAR by molecular topology of 2,4-dihydroxythiobenzanilides-·A virtual screening approach to optimize the antifungal activity , 2002 .
[23] S. Basak,et al. Usefulness of graphical invariants in quantitative structure–activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type , 2004, Journal of molecular modeling.
[24] Emili Besalú,et al. Fast Computation of Cross-Validated Properties in Full Linear Leave-Many-Out Procedures , 2001 .
[25] D. Gadre,et al. In vitro susceptibility testing of Mycobacterium tuberculosis strains to trifluoperazine. , 1999, Journal of chemotherapy.
[26] Jouko Yliruusi,et al. Prediction of physicochemical properties based on neural network modelling. , 2003, Advanced drug delivery reviews.
[27] W. Doucette. Quantitative structure‐activity relationships for predicting soil‐sediment sorption coefficients for organic chemicals , 2003, Environmental toxicology and chemistry.
[28] J P Doucet,et al. Application of topological descriptors in QSAR and drug design: history and new trends. , 2002, Current drug targets. Infectious disorders.
[29] J. Gálvez. Use of molecular topology in the selection of new cytostatic drugs , 2000 .
[30] S. Agatonovic-Kustrin,et al. Molecular descriptors that influence the amount of drugs transfer into human breast milk. , 2002, Journal of pharmaceutical and biomedical analysis.
[31] Martha Windholz. The Merck index: an encyclopedia of chemicals, drugs, and biologicals , 1983 .
[32] K. Schaper,et al. Substituted Xanthones as Antimycobacterial Agents , 1999 .
[33] J. Gálvez,et al. New bronchodilators selected by molecular topology. , 1998, Bioorganic & medicinal chemistry letters.
[34] L Pastor,et al. New antifungals selected by molecular topology. , 1998, Bioorganic & medicinal chemistry letters.
[35] Anton J Hopfinger,et al. Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives. , 2004, Journal of medicinal chemistry.
[36] D. Sureja,et al. Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents. , 2001, Bioorganic & medicinal chemistry.
[37] Jorge Gálvez,et al. Charge Indexes. New Topological Descriptors , 1994, J. Chem. Inf. Comput. Sci..
[38] H. Wiener. Structural determination of paraffin boiling points. , 1947, Journal of the American Chemical Society.
[39] R. García-Domenech,et al. Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds. , 1999, Journal of medicinal chemistry.
[40] Rafael Gozalbes,et al. Prediction of Quinolone Activity against Mycobacterium avium by Molecular Topology and Virtual Computational Screening , 2000, Antimicrobial Agents and Chemotherapy.
[41] E. Bouza,et al. In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis That Are Susceptible or Resistant to First-Line Antituberculous Drugs , 2003, Antimicrobial Agents and Chemotherapy.
[42] M. Randic,et al. The connectivity index 25 years after. , 2001, Journal of molecular graphics & modelling.
[43] J. Gálvez,et al. Pharmacological distribution diagrams: a tool for de novo drug design. , 1996, Journal of molecular graphics.
[44] G. Marshall,et al. Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies. , 2000, Bioorganic & medicinal chemistry.
[45] L B Kier,et al. Molecular connectivity V: connectivity series concept applied to density. , 1976, Journal of pharmaceutical sciences.
[46] R. Kaliszan,et al. Imidazo[4,5‐b]pyridine Derivatives of Potential Tuberculostatic Activity. Part 1: Synthesis and Quantitative Structure‐Activity Relationships , 1991, Archiv der Pharmazie.
[47] Jesús Vicente de Julián-Ortiz,et al. Topological Approach to Drug Design , 1995, J. Chem. Inf. Comput. Sci..
[48] M. J. Duart,et al. Search of a Topological Pattern to Evaluate Toxicity of Heterogeneous Compounds , 2001, SAR and QSAR in environmental research.
[49] E. Ferreira,et al. Potential tuberculostatic agents. Topliss application on benzoic acid [(5-nitro-thiophen-2-yl)-methylene]-hydrazide series. , 2002, Bioorganic & medicinal chemistry.
[50] Ramón García-Domenech,et al. Search for New Antihistaminic Compounds by Molecular Connectivity , 1999 .
[51] W. P. Dixon,et al. BMPD statistical software manual , 1988 .
[52] Prediction of chromatographic properties of organophosphorus Insecticides by molecular connectivity , 2000 .
[53] Braun. [Chemotherapy of tuberculosis of the skin]. , 1950, Archiv für Dermatologie und Syphilis.
[54] Ramón García-Domenech,et al. Designing sedative/hypnotic compounds from a novel substructural graph-theoretical approach , 1998, Journal of computer-aided molecular design.
[55] E Estrada,et al. Novel local (fragment-based) topological molecular descriptors for QSpr/QSAR and molecular design. , 2001, Journal of molecular graphics & modelling.
[56] George M. Furnival,et al. Regressions by leaps and bounds , 2000 .